DermTech Return on Tangible Equity 2017-2024 | DMTKQ
Current and historical return on tangible equity values for DermTech (DMTKQ) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| DermTech Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-03-31 | $-0.09B | $0.04B | -137.98% |
| 2023-12-31 | $-0.10B | $0.06B | -123.08% |
| 2023-09-30 | $-0.11B | $0.07B | -109.00% |
| 2023-06-30 | $-0.12B | $0.09B | -98.76% |
| 2023-03-31 | $-0.12B | $0.11B | -82.37% |
| 2022-12-31 | $-0.12B | $0.13B | -69.96% |
| 2022-09-30 | $-0.12B | $0.16B | -59.97% |
| 2022-06-30 | $-0.11B | $0.18B | -49.07% |
| 2022-03-31 | $-0.09B | $0.20B | -39.08% |
| 2021-12-31 | $-0.08B | $0.23B | -31.01% |
| 2021-09-30 | $-0.06B | $0.25B | -30.07% |
| 2021-06-30 | $-0.05B | $0.27B | -32.60% |
| 2021-03-31 | $-0.05B | $0.26B | -41.86% |
| 2020-12-31 | $-0.04B | $0.06B | -61.67% |
| 2020-09-30 | $-0.03B | $0.05B | -67.37% |
| 2020-06-30 | $-0.03B | $0.06B | -73.89% |
| 2020-03-31 | $-0.02B | $0.07B | -89.32% |
| 2019-12-31 | $-0.02B | $0.01B | -204.88% |
| 2019-09-30 | $-0.01B | $0.02B | -193.10% |
| 2019-06-30 | $-0.01B | $0.01B | -266.67% |
| 2019-03-31 | $-0.01B | $0.01B | -16.11% |
| 2018-09-30 | $-0.00B | $0.01B | -5.19% |
| 2018-06-30 | $0.00B | $0.14B | 0.00% |
| 2017-06-30 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.002B | $0.015B |
| DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known as Constellation Alpha Capital Corp., is based in La Jolla, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.272B | 15.47 |
| Cencora (COR) | United States | $44.378B | 17.30 |
| ICON (ICLR) | Ireland | $26.234B | 24.77 |
| DiDi Global (DIDIY) | China | $19.879B | 0.00 |
| Avantor (AVTR) | United States | $14.271B | 21.01 |
| CochLear (CHEOY) | Australia | $13.967B | 0.00 |
| Natera (NTRA) | United States | $13.710B | 0.00 |
| Revvity (RVTY) | United States | $12.655B | 22.20 |
| Medpace Holdings (MEDP) | United States | $12.488B | 41.09 |
| Viatris (VTRS) | United States | $12.359B | 3.69 |
| Charles River Laboratories (CRL) | United States | $10.375B | 19.86 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.322B | 0.00 |
| Solventum (SOLV) | United States | $8.782B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| HealthEquity (HQY) | United States | $7.271B | 46.68 |
| Organon (OGN) | United States | $5.223B | 4.95 |
| Bausch + Lomb (BLCO) | Canada | $5.158B | 20.65 |
| Doximity (DOCS) | United States | $4.890B | 34.25 |
| PACS (PACS) | United States | $4.570B | 0.00 |
| Life Times (LTH) | United States | $3.712B | 38.90 |
| Sotera Health (SHC) | United States | $3.298B | 16.18 |
| Surgery Partners (SGRY) | United States | $2.999B | 27.44 |
| GoodRx Holdings (GDRX) | United States | $2.930B | 111.57 |
| Progyny (PGNY) | United States | $2.691B | 46.33 |
| Agilon Health (AGL) | United States | $2.463B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.938B | 0.00 |
| Premier (PINC) | United States | $1.926B | 8.24 |
| AMN Healthcare Services Inc (AMN) | United States | $1.875B | 7.43 |
| Teladoc Health (TDOC) | United States | $1.565B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.520B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.467B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.203B | 0.00 | |
| CareDx (CDNA) | United States | $0.776B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.731B | 0.00 |
| Embecta (EMBC) | United States | $0.696B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.688B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.597B | 6.34 |
| Auna S.A (AUNA) | Luxembourg | $0.591B | 0.00 |
| Sharecare (SHCR) | United States | $0.500B | 0.00 |
| Enhabit (EHAB) | United States | $0.439B | 43.80 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.421B | 0.00 |
| ModivCare (MODV) | United States | $0.387B | 7.23 |
| QDM (QDMI) | Hong Kong, SAR China | $0.353B | 9.24 |
| DocGo (DCGO) | United States | $0.299B | 16.33 |
| LifeMD (LFMD) | United States | $0.283B | 0.00 |
| Beauty Health (SKIN) | United States | $0.241B | 0.00 |
| Biodesix (BDSX) | United States | $0.184B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.181B | 0.00 |
| MultiPlan (MPLN) | United States | $0.177B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.176B | 0.00 |
| So-Young (SY) | China | $0.104B | 50.25 |
| Pono Capital Two (PTWO) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 5.87 |
| Co-Diagnostics (CODX) | United States | $0.040B | 0.00 |
| Oncology Institute (TOI) | United States | $0.036B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| OncoCyte (OCX) | United States | $0.025B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.025B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| KindlyMD (KDLY) | $0.015B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |